Filtered By:
Specialty: Neurology
Condition: Migraine
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 835 results found since Jan 2013.
Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19
Curr Alzheimer Res. 2022 Sep 8. doi: 10.2174/1567205019666220908084559. Online ahead of print.ABSTRACTThe COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2), a respiratory pathogen with neuroinvasive potential. Neurological COVID-19 manifestations include loss of smell and taste, headache, dizziness, stroke, and potentially fatal encephalitis. Several studies found elevated proinflammatory cytokines such as TNF-α, IFN-γ, IL-6 IL-8, IL-10 IL-16, IL-17A, and IL-18 in severely and critically ill COVID-19 patients, which may persist even after apparent recovery from infection. Bioma...
Source: Current Alzheimer Research - September 12, 2022 Category: Neurology Authors: Christos Tsagkaris Muhammad Bilal Irem Aktar Youssef Aboufandi Ahmet Tas Abdullahi Tunde Aborode Tarun Kumar Suvvari Shoaib Ahmad Anastasiia Shkodina Rachana Phadke Marwa S Emhamed Atif Amin Baig Athanasios Alexiou Ghulam Md Ashraf Mohammad Amjad Kamal Source Type: research
Therapeutic Approaches to the Neurologic Manifestations of COVID-19
AbstractAs of May 2022, there have been more than 527 million infections with severe acute respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from Coronavirus Disease 2019 (COVID-19) worldwide. COVID-19 is a multisystem illness with important neurologic consequences that impact long-term morbidity and mortality. In the acutely ill, the neurologic manifestations of COVID-19 can include distressing but relatively benign symptoms such as headache, myalgias, and anosmia; however, entities such as encephalopathy, stroke, seizures, encephalitis, and Guillain –Barre Syndrome can cause neurologic inj...
Source: Neurotherapeutics - July 21, 2022 Category: Neurology Source Type: research
A questionnaire-based survey of acceptability and satisfaction of virtual neurology clinic during COVID-19 lockdown: a preliminary study
DiscussionTeleneurology facility is not only feasible but also affordable and acceptable in various neurological conditions. The chief reasons being no waiting time, saving of travelling time and travel expenditure with good satisfaction.
Source: Acta Neurologica Belgica - July 7, 2022 Category: Neurology Source Type: research
The spectrum of Neuro-COVID: A study of a comprehensively investigated large cohort from India
Conclusion: Stroke and encephalopathy constitute the most common neurological manifestations. The absence of preceding COVID-19 symptoms in nearly half the cases is striking. Poor outcome was seen in nearly 50% despite early recognition and management.
Source: Annals of Indian Academy of Neurology - May 25, 2022 Category: Neurology Authors: Seena Vengalil Rohan Mahale N Chakradhar Swathi Alluri PR Sagar Navanith VH Ganaraja KR Haripriya Holla Venkappayya Vikram Ajay Asranna Pooja Mailankody Doniparthi V Seshagiri H Manoj Cheerla VN Maturu CR Vaddepally Raghavendra Kenchaiah PR Srijithesh Jay Source Type: research
Neurological manifestations of COVID ‐19: A potential gate to the determinants of a poor prognosis
ConclusionCOVID-19 neurologic complications are key drivers of patient severity and mortality. Headache, convulsions, mental and psychic disorders, delirium, and insomnia are just some of the symptoms that the virus can cause. The olfactory nerve is the most commonly damaged cranial nerve, resulting in anosmia. Stroke (mostly infarction), encephalitis, meningitis, Guillain –Barre syndrome, relapse of multiple sclerosis, and transverse myelitis are all symptoms and squeals.
Source: Brain and Behavior - April 27, 2022 Category: Neurology Authors: Etedal Ahmed A. Ibrahim,
Ramah Isam Farah Hassan,
Khabab Abbasher Hussien Mohamed Ahmed,
Elmuntasir Taha Salah,
Mohammed Eltahier Abdalla Omer,
Mazin S. Haroun Tags: REVIEW Source Type: research
Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series
We report 8 patients with focal neurological symptoms after receiving inactivated virus vaccine, CoronaVac.Case seriesPatients were aged 24 –48 years and 75% were female. Acute onset of focal neurological symptoms occurred within the first 24 h after vaccination in 75% and between 1-7d in 25%. All presented with lateralized sensory deficits, motor deficits, or both, of 2–14 day duration. Migraine headache occurred in half of t he patients. Magnetic resonance imaging of the brain during and after the attacks did not demonstrate any abnormalities suggesting ischemic stroke. All patients showed moderately large regi...
Source: The Journal of Headache and Pain - January 21, 2022 Category: Neurology Source Type: research
Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study
ConclusionsNeurological symptoms are frequent among patients with COVID-19. Encephalopathy was the most frequent neurological complication and was associated with a higher mortality. Those with anosmia had a lower mortality.
Source: Acta Neurologica Belgica - January 21, 2022 Category: Neurology Source Type: research
Fulminant reversible cerebral vasoconstriction syndrome in breakthrough COVID 19 infection
We report a case of fulminant reversible cerebrovascular constriction syndrome (RCVS) in a patient with breakthrough COVID 19 infection who was fully vaccinated. A 64 year old lady, fully vaccinated 2 months back, presented with headache, drowsiness, partial seizures, visual impairment and quadriplegia. Her nasopharyngeal swab was tested positive for SARS COV2 on real time PCR assay.
Source: Journal of Stroke and Cerebrovascular Diseases - November 25, 2021 Category: Neurology Authors: Somdattaa Ray, Vikram V Kamath, Arjun Raju P, Rajesh K.N, Shalini N Source Type: research
Pharmacotherapy for SARS-CoV-2 and Seizures for drug repurposing presumed on Mechanistic Targets
CONCLUSION: These findings would hopefully provide the basis for initiating further studies on the pathogenesis and drug targeting strategies for this emerging infection accompanied with seizures or in people with epilepsy.PMID:34645381 | DOI:10.2174/1874467214666211013122528
Source: Epilepsy Curr - October 14, 2021 Category: Neurology Authors: Divya Goel Ankit Srivastava Ángel Aledo-Serrano Anuja Krishnan Divya Vohora Source Type: research
